(S)-2-((S)-Pyrrolidine-2-carboxamido)propanoic acid is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting neurological and metabolic disorders. Its chiral structure makes it valuable in the production of enantiomerically pure drugs, enhancing their efficacy and reducing potential side effects. Additionally, it is explored in peptide chemistry for designing novel peptide-based therapeutics, due to its ability to influence peptide conformation and stability. Researchers also investigate its potential in enzyme inhibition studies, particularly in enzymes involved in neurodegenerative diseases.